Chronic expression of DUX4 in mice did not induce changes in the blood eosinophil composition in the mid and late stages of FSHD progression, suggesting that changes in eosinophil release from the bone marrow are unlikely to happen at these stages. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.